275 related articles for article (PubMed ID: 34827688)
21. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
Landry M; Pomerleau V; Saucier C
Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains.
Woodside DG; Obergfell A; Talapatra A; Calderwood DA; Shattil SJ; Ginsberg MH
J Biol Chem; 2002 Oct; 277(42):39401-8. PubMed ID: 12171941
[TBL] [Abstract][Full Text] [Related]
23. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
24. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
25. The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling.
Margolis B
J Lab Clin Med; 1996 Sep; 128(3):235-41. PubMed ID: 8783629
[TBL] [Abstract][Full Text] [Related]
26. Interaction of phosphorylated FcepsilonRIgamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics.
Chen T; Repetto B; Chizzonite R; Pullar C; Burghardt C; Dharm E; Zhao Z; Carroll R; Nunes P; Basu M; Danho W; Visnick M; Kochan J; Waugh D; Gilfillan AM
J Biol Chem; 1996 Oct; 271(41):25308-15. PubMed ID: 8810294
[TBL] [Abstract][Full Text] [Related]
27. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
28. Evolution of SH2 domains and phosphotyrosine signalling networks.
Liu BA; Nash PD
Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1602):2556-73. PubMed ID: 22889907
[TBL] [Abstract][Full Text] [Related]
29. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.
Ravichandran KS; Zhou MM; Pratt JC; Harlan JE; Walk SF; Fesik SW; Burakoff SJ
Mol Cell Biol; 1997 Sep; 17(9):5540-9. PubMed ID: 9271429
[TBL] [Abstract][Full Text] [Related]
31. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
32. Src homology 2 domain-based high throughput assays for profiling downstream molecules in receptor tyrosine kinase pathways.
Yaoi T; Chamnongpol S; Jiang X; Li X
Mol Cell Proteomics; 2006 May; 5(5):959-68. PubMed ID: 16477079
[TBL] [Abstract][Full Text] [Related]
33. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site.
Bae JH; Lew ED; Yuzawa S; Tomé F; Lax I; Schlessinger J
Cell; 2009 Aug; 138(3):514-24. PubMed ID: 19665973
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin.
Kapeller R; Moriarty A; Strauss A; Stubdal H; Theriault K; Siebert E; Chickering T; Morgenstern JP; Tartaglia LA; Lillie J
J Biol Chem; 1999 Aug; 274(35):24980-6. PubMed ID: 10455176
[TBL] [Abstract][Full Text] [Related]
35. Association between mitogen-activated protein kinase and the zeta chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking.
August A; Dupont B
J Biol Chem; 1996 Apr; 271(17):10054-9. PubMed ID: 8626561
[TBL] [Abstract][Full Text] [Related]
36. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
37. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.
Borg JP; Ooi J; Levy E; Margolis B
Mol Cell Biol; 1996 Nov; 16(11):6229-41. PubMed ID: 8887653
[TBL] [Abstract][Full Text] [Related]
38. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
[TBL] [Abstract][Full Text] [Related]
39. [Functional roles of phosphotyrosine adaptor Shc in the brain].
Kakizawa S
Nihon Yakurigaku Zasshi; 2018; 152(2):84-89. PubMed ID: 30101865
[TBL] [Abstract][Full Text] [Related]
40. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
Marengere LE; Pawson T
J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
